Sun Pharma launches Ilumya for psoriasis treatment in IndiaSun Pharmaceutical Industries has launched its innovative drug Ilumya in India. This medication treats moderate-to-severe plaque psoriasis....
01 Dec, 2025, 07.23 PM IST
Sun Pharma brings global psoriasis drug ILUMYA to Indian marketSun Pharmaceutical Industries has launched its innovative biologic drug, ILUMYA, in India for moderate-to-severe plaque psoriasis. This nov...
01 Dec, 2025, 11.28 AM IST
Eli Lilly forays into dermatological space with launch of psoriasis drugEli Lilly has launched a new drug to treat moderate-to-severe plaque psoriasis in India. The drug, Copellor, is designed to specifically ta...
14 Mar, 2023, 12.18 PM IST
Unichem Laboratories gets USFDA nod for plaque psoriasis treatment drugApremilast tablets are indicated for the treatment of adult patients with moderate to severe plaque psoriasis who are candidates for photot...
19 Feb, 2021, 11.55 AM IST
Sun Pharma arm launches plaque psoriasis treatment drug in JapanIn a regulatory filing, Sun Pharmaceutical Industries said its "wholly-owned Japanese subsidiary has launched Ilumya Subcutaneous Injection...
23 Sep, 2020, 10.40 AM IST
Sun Pharma, Hikma ink exclusive pact for plaque psoriasis drug for MENA regionUnder the terms of the licensing agreement, Hikma will be responsible for the registration and commercialisation of the product in all MENA...
15 Jun, 2020, 01.47 PM IST
Alembic Pharma JV gets USFDA nod for plaque psoriasis treatment drugAlembic has a cumulative total of 103 ANDA approvals (91 final approvals and 12 tentative approvals) from USFDA.
04 Oct, 2019, 11.42 AM IST
New psoriasis drug study yields positive results: Dr Reddy'sAccording to a press release from the city-based drug-maker, the detailed safety and efficacy data from the study would be presented in fut...
10 Jun, 2019, 02.25 PM IST
Lupin launches plaque psoriasis treatment spray in US marketQuoting IQVIA MAT May 2018 data, Lupin said Desoximetasone Topical Spray, 0.25 per cent, had annual sales of approximately USD 18.7 million...
27 Jul, 2018, 12.57 PM IST
Sun Pharma climbs over 3% after USFDA drug nodThe company informed stock exchanges about the USFDA nod after market hours of Wednesday.
22 Mar, 2018, 12.25 PM IST
Tildra approval to give sentimental push to Sun PharmaThe drug which will be sold under the brand name Ilumya is expected to treat adults for moderate to severe plaque psoriasis, an autoimmune ...
22 Mar, 2018, 09.24 AM IST
Sun Pharma gets USFDA nod for plaque psoriasis drugThe FDA approval of the drug was supported by data from the pivotal phase-3 resurface clinical development program, it said.
21 Mar, 2018, 11.29 PM IST
Sun Pharma signs licening pact with spanish firm Almirall for psoriasis drugIn return, the Indian company will receive an initial upfront payment of $50 million and be eligible for development and regulatory milesto...
28 Jul, 2016, 08.12 AM IST
Novartis Healthcare launches psoriasis treatment drug in IndiaNovartis Healthcare has launched secukinumab, used for the treatment of plaque psoriasis in adult patients, in India. The company has launc...
17 Mar, 2016, 06.49 PM IST
Glenmark gets tentative USFDA nod for generic psoriasis creamGlenmark said in a statement that the product is the therapeutic equivalent of Danish pharma firm Leo Pharma A/S Dovonex's topical cream of...
04 May, 2015, 01.50 PM IST
Sun Pharma, Merck & Co Inc enter into pact for TildrakizumabUnder terms of the agreement, Sun Pharma will acquire worldwide rights to tildrakizumab for use in all human indications from Merck.
17 Sep, 2014, 08.05 PM IST
Biocon gets DCGI approval to market anti-psoriasis drug, Itolizumab"The company has received market authorisation from the DCGI for its novel biologic Itolizumab, for treatment of chronic plaque psoriasis,"...
08 Jan, 2013, 02.27 PM IST